









Markets
/
Stocks
/
nasdaq-aard
/

Aardvark Therapeutics Inc

AARD

14.780USD

+0.230+1.58%

Market hours （ET）Quotes delayed by 15 min

321.40MMarket Cap

LossP/E TTM



Aardvark Therapeutics Inc

14.780

+0.230+1.58%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Aardvark Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

Total equity

Cash, cash equivalents and short-term investments

53.41%126.35M

64.24%141.82M

--151.26M

--73.66M

--82.36M

--86.35M

- Cash and cash equivalents

-52.25%39.28M

-69.83%26.00M

--26.50M

--61.64M

--82.28M

--86.17M

-Short-term investments

104797.59%87.06M

66464.37%115.82M

--124.76M

--12.02M

--83.00K

--174.00K

Prepaid expenses

1580.59%2.86M

562.47%2.95M

--3.29M

--314.00K

--170.00K

--445.00K

Other current assets

-100.00%0.00

--0.00

--160.00K

--136.00K

--197.00K

Total current assets

56.30%129.21M

66.42%144.77M

--154.55M

--74.14M

--82.67M

--86.99M

Non-current assets

Net Fixed Assets

-47.80%439.00K

397.14%522.00K

--628.00K

--735.00K

--841.00K

--105.00K

Other non-current assets

1444.40%3.58M

1923.15%2.19M

--1.84M

--2.63M

--232.00K

--108.00K

Total non-current assets

274.84%4.02M

1170.89%2.71M

--2.47M

--3.37M

--1.07M

--213.00K

Total assets

59.10%133.23M

69.12%147.47M

--157.03M

--77.51M

--83.74M

--87.20M

Liabilities

Current liabilities

-Other payables

--320.00K

--307.00K

--635.00K

----

Accrued expenses

241.53%5.54M

240.35%4.53M

--3.53M

--2.29M

--1.62M

--1.33M

Other current liabilities

--320.00K

--307.00K

--635.00K

----

Total current liabilities

311.03%10.74M

287.16%10.31M

--5.98M

--4.93M

--2.61M

--2.66M

Non-current liabilities

Long-term debt and lease liabilities

-78.72%116.00K

--228.00K

--336.00K

--441.00K

--545.00K

--0.00

-Long-term lease liabilities

-78.72%116.00K

--228.00K

--336.00K

--441.00K

--545.00K

--0.00

Other non-current liabilities

--0.00

--12.00K

--24.00K

--26.00K

--0.00

Total non-current liabilities

-78.72%116.00K

--240.00K

--360.00K

--467.00K

--545.00K

--0.00

Total liabilities

243.74%10.85M

296.17%10.55M

--6.34M

--5.39M

--3.16M

--2.66M

Shareholders' equity

Common equity

6438.68%220.62M

7054.65%218.93M

--218.28M

--3.68M

--3.37M

--3.06M

Preferred equity

----

--126.76M

--126.84M

Retained earnings

-98.43%-98.32M

-80.76%-82.00M

---67.64M

---58.33M

---49.55M

---45.37M

Capital reserves

6438.68%220.62M

7054.64%218.93M

--218.28M

--3.68M

--3.37M

--3.06M

Gains losses not affecting retained earnings

--82.00K

---3.00K

--44.00K

----

Total equity

51.87%122.38M

61.97%136.93M

--150.69M

--72.11M

--80.58M

--84.54M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

